Bridge Bio Pharma, Inc. Eidos Therapeutics, Inc. (EIDX) insider trading activity

EIDX Quotes by TradingView

Bridge Bio Pharma, Inc. is > 10% Shareholder of Eidos Therapeutics, Inc.. Currently has a direct ownership of 1,000 shares of EIDX, which is worth approximately $122,010. The most recent transaction as insider was on Jan 26, 2021, when has been sold 14,428,836 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1K
0% 3M change
0% 12M change
Total Value Held $122,010

BridgeBio Pharma, Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2021
BUY
Open market or private purchase
-
14,428,836 Added 99.99%
1,000 Common Stock
BPI

Bridge Bio Pharma, Inc.

> 10% Shareholder
Palo Alto, CA

Track Institutional and Insider Activities on EIDX

Follow Eidos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EIDX shares.

Notify only if

Insider Trading

Get notified when an Eidos Therapeutics, Inc. insider buys or sells EIDX shares.

Notify only if

News

Receive news related to Eidos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EIDX